Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial
Yin, John A. Liu, O'Brien, Michelle A., Hills, Robert K., Daly, Sarah B., Wheatley, Keith, Burnett, Alan K.
Published in Blood (04.10.2012)
Published in Blood (04.10.2012)
Get full text
Journal Article